Rubicon Organics Inc. (ROMJ.V)

CAD 0.4

(-1.25%)

Net Debt Summary of Rubicon Organics Inc.

  • Rubicon Organics Inc.'s latest annual net debt in 2023 was 475.37 Thousand CAD , down -67.9% from previous year.
  • Rubicon Organics Inc.'s latest quarterly net debt in 2024 Q1 was 2.67 Million CAD , up 332.78% from previous quarter.
  • Rubicon Organics Inc. reported annual net debt of 1.92 Million CAD in 2022, up 208.86% from previous year.
  • Rubicon Organics Inc. reported annual net debt of -1.76 Million CAD in 2021, down -195.61% from previous year.
  • Rubicon Organics Inc. reported quarterly net debt of 2.67 Million CAD for 2024 Q1, up 332.78% from previous quarter.
  • Rubicon Organics Inc. reported quarterly net debt of 1.36 Million CAD for 2023 Q3, up 34.87% from previous quarter.

Annual Net Debt Chart of Rubicon Organics Inc. (2023 - 2016)

Historical Annual Net Debt of Rubicon Organics Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 475.37 Thousand CAD -67.9%
2022 1.92 Million CAD 208.86%
2021 -1.76 Million CAD -195.61%
2020 1.84 Million CAD -83.49%
2019 11.19 Million CAD 257.8%
2018 3.13 Million CAD 1362.12%
2017 214.08 Thousand CAD 106.22%
2016 -3.44 Million CAD 0.0%

Peer Net Debt Comparison of Rubicon Organics Inc.

Name Net Debt Net Debt Difference
Aequus Pharmaceuticals Inc. 4.89 Million CAD 90.286%
CanadaBis Capital Inc. 4.08 Million CAD 88.36%
Decibel Cannabis Company Inc. 37.48 Million CAD 98.732%
Delivra Health Brands Inc. -2.17 Million CAD 121.876%
Entourage Health Corp. 150.32 Million CAD 99.684%
Lifeist Wellness Inc. -188.12 Thousand CAD 352.684%
Cannara Biotech Inc. 41.51 Million CAD 98.855%
Medicure Inc. -5.82 Million CAD 108.161%
PharmaCielo Ltd. 18.24 Million CAD 97.395%
BioSyent Inc. -3.68 Million CAD 112.9%
Voyageur Pharmaceuticals Ltd. 37.91 Thousand CAD -1153.783%